NEW YORK, Sept. 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2014 Opportunities in the US Blood Banking Market http://www.reportlinker.com/p01622683/2014-Opportunities-in-the-US-Blood-Banking-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

Rationale

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.- Alternative market penetration strategies.- Potential market entry barriers and risks.

The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leadingsuppliers of blood banking of reagentsand instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and newproducts in R&D.

Market Segmentation Analysis

- Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers.

- Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:

- Blood Centers- Plasma Fractionation Facilities- Hospitals- Commercial/Private Laboratories- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automatedanalyzers, including their operating characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,and their potential applications for the blood banking market.

- Comprehensive lists of companies developingor marketing new technologies and products by test.

Contains 460 pages and 53 tables

I. Introduction

II. Major Product Development Opportunities

A. Blood Typing and GroupingB. Infectious Disease ScreeningC. Auxiliary

III. Alternative Market Penetration Strategies

A. Internal DevelopmentB. Collaborative ArrangementsC. University Contracts

IV. Potential Market Entry Barriers and Risks

A. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent Protection

V. Worldwide Technology and Market Overview

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests1. Blood Typing and Grouping Testsa. ABOb. Antibody Panelsc. Antibody Screeningd. Antigen Typinge. Antiglobulin Testf. Crossmatchg. HLA Typingh. Rhi. Other Blood Groups2. Infectious Disease Screening Testsa. AIDS- Structure and Composition- Classification- Origin of AIDS- Animal Lentivirus Systems- Virus Receptors- HIV Infections in Humans° Pathogenesis & Pathology° Overview of Course of HIV Infection- CD4T Lymphocytes and Memory Cells- Monocytes and Macrophages- Lymphoid Organs- Neural Cells- Viral Coinfections° Clinical Findings- Plasma Viral Load- Pediactric AIDS° Neurologic Disease° Opportunistic Infections° Protozoa° Fungi° Bacteria- Viruses- Cancer - Immunity- Laboratory Diagnosis° Virus Isolation

° Serology° Detection of Viral Nucleic Acid or Antigens- Epidemiology° Worldwide Spread of AIDS° United States° Routes of Transmission- Prevention, Treatment, And Control° Antiviral Drugs° Vaccines Against HIV- Transmission of HIV in Blood Products- HIV Transmission in Transplant and Artificial Insemination Recipients- Diagnostic Tests° Enzyme Immunoassay Interpretation° Specificity, Sensitivity, and PredictiveValue of Enzyme Immunoassay- Competition Assays- Western Blot Technique- Immuno-Fluorescence Assay (IFA)- Radioimmunoprecipitation- HIV-1/HIV-2 Combination Testing- Methods of HIV-Antigen Detection- Antigen Assays and Blood Screening- Urine Tests- DNA Probes° Overview° Quantitative Polymerase Chain Reaction° In Situ PCR° Needed Improvements- Viral Load/Drug Resistance Testing- Genotype and Phenotype Testing- Blood Banking Considerationsb. Hepatitis- Hepatitis A- Hepatitis B° Structure and Composition° Replication of Hepatitis B Virus- Hepatitis C- Hepatitis D (Delta Hepatitis)- Hepatitis E- Hepatitis G

- Hepatitis Virus Infections In Humans° Pathology- Clinical Findings- Laboratory Features° Hepatitis A° Hepatitis B° Hepatitis C° Hepatitis D° Hepatitis E- Virus-Host Immune Reactions- Epidemiology° Hepatitis A° Hepatitis B° Hepatitis C° Hepatitis D (Delta Agent)- Vaccines and Drugsc. Cytomegalovirus- Background- Chorioretinitis- Gastrointestinal- Central Nervous System Disease- Diagnostic Tests- Vaccines and Drugsd. Syphilis- Background- Diagnostic Tests- Vaccines and Drugse. West Nile Virus- Background- Clinical Syndromes- Diagnostic Tests- Vaccines and Drugsf. Parvovirus B19- Microbiology- Epidemiology- Clinical Syndromes° Erythema Infectiosum Slapped (cheek)° Adult Polyarthropathy

° Transient Aplastic Crisis° Transient Pancytopenia° Red Cell Aplasia in the Immunocompromised° Perinatal Infections- Diagnosis- Treatmentg. Creutzfeldt-Jakob's Disease- Background- Transmission- Diagnostic Tests- Major Commercial and Academic Players° Bayer° Disease Sciences/BioTec Global° Imperial College School of Medicine° Ortho-Clinical Diagnostics° Pall° ProMetic Life Sciences° Proteome Sciences/Idexx° Q-One Biotech° Serono° U.S. Agricultural Research Service- Drugs- Vaccinesh. Malariai. Chagas Diseasej. Babesiosis3. Pathogen Reduction4. Leukocyte Reduction- Background- MethodsB. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by: - Abbott- Beckman Coulter/Danaher- Bio-Rad- BioMerieux- Gen-Probe- Grifols- Immucor- Nanosphere

- Ortho-Clinical Diagnostics- Roche- Sarstedt- Siemens- TecanC. Major in Vitro Diagnostic TechnologiesAnd Their Potential Applications1. Molecular Diagnosticsa. Overviewb. NAT2. Monoclonal and Polyclonal Antibodies3. Immunoassaysa. Technological Principleb. Chemiluminescence c. Enzyme Immunoassays (EIA)- Overview- ELISA- EMIT- Electrochemicald. Radioimmunoassays (RIA)e. Immunoprecipitationf. Affinity Chromatography4. Microtitration Plates5. IT and Automation6. Lasers7. Robotics8. Synthetic Red Cell Substitutes9. Genetically Engineered Blood Componentsa. Albuminb. Factor VIIIc. Alpha-2 Antiplasmind. Antithrombin IIIe. Factor IXf. Von Willebrand's Factorg. Fibrinogenh. t-PA10. Blood Preservation11. Autologous Blood Transfusion/Freezing

VI. U.S.A.

A. Executive SummaryB. Business Environment1. Overview2. Health Care Expenditures3 Cost Consciousness4. Industry Consolidation5. Managed Care6. Hospitals7. Admissions8. Length of Stay9. Industry Diversification10. Physician Demographics11. Population Aginga. Chronic Illnessesb. Disease Incidencec. Susceptibility to Latrogenesisd. Multiple Illness Cases12. Laboratory RegulationsC. Market StructureD. Market Size, Growth and Major Suppliers'Sales and Market Shares

VII. Competitive Assessments

- Abbott- Beckman Coulter/Danaher- Becton Dickinson- Biokit- BioMerieux- Bio-Rad- Diagast- DiaSorin- Fujirebio/Innogenetics- Hologic/Gen-Probe- Grifols- Immucor- Novartis Diagnostics- Ortho-Clinical Diagnostics- Orchid CellMark- Proteome Sciences - Quest Diagnostics- Quidel- Roche- Siemens- Tecan

VIII. Appendix: Assumed Currency Exchange Rates

List of Tables

Major Companies Developing or MarketingBlood Typing and Grouping TestsMajor Companies Developing or MarketingHLA Typing TestsMajor Companies Developing or MarketingAIDS TestsMajor Companies Developing or MarketingHepatitis TestsMajor Companies Developing or MarketingCMV TestsMajor Companies Developing or MarketingSyphilis TestsMajor Companies Developing or MarketingBlood Bank AnalyzersExecutive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast by Test CategoryU.S.A., Estimated Number of Inpatient andAmbulatory SurgeriesU.S.A., Facilities Performing BloodBank Tests by Market SegmentU.S.A., Hospital Laboratories PerformingBlood Bank Tests by Bed SizeU.S.A., Commercial/Private LaboratoriesPerforming Blood Bank Tests by Annual Test Volume ForecastU.S.A., Facilities Collecting Whole BloodAnd Plasma by Market Forecast SegmentU.S.A., Whole Blood and Plasma CollectionsBy Market Forecast SegmentU.S.A., All Market Segments Blood Typingand Grouping Test Volume by Market Forecast SegmentU.S.A., All Market Segments Blood Typing

And Grouping Test Volume ForecastU.S.A., Hospital Laboratories BloodTyping and Grouping Test Volume ForecastU.S.A., Community and Regional Blood CentersBlood Typing and Grouping Test Volume ForecastU.S.A., Commercial/Private LaboratoriesBlood Typing and Grouping Test Volume ForecastU.S.A., Plasma Fractionation Centers BloodTyping and Grouping Test Volume ForecastU.S.A., Military Blood Banks Blood Typingand Grouping Test Volume ForecastU.S.A., All Market Segments InfectiousDisease Screening Test Volume Forecast By Market SegmentU.S.A., All Market Segments InfectiousDisease Screening Test Volume ForecastU.S.A., Community and Regional Centers Infectious Disease Screening Test Volume ForecastU.S.A., Plasma Fractionation CentersInfectious Disease Screening Test Volume ForecastU.S.A., Hospital Blood BanksInfectious Disease Screening Test Volume ForecastU.S.A., Military Blood Banks InfectiousDisease Screening Test Volume ForecastU.S.A., All Market Segments Blood TypingAnd Grouping Reagent Market Forecast by Market Segment

U.S.A., All Market Segments Blood TypingAnd Grouping Reagent Market Forecast by Market SegmentU.S.A., Hospital Blood Banks Blood TypingAnd Grouping Reagent Market Forecast by Major Test U.S.A., Community and Regional Blood CentersBlood Typing and Grouping Reagent Market Forecast By Major TestU.S.A., Commercial/Private LaboratoriesBlood Typing and Grouping Reagent Market ForecastBy Major TestU.S.A., Plasma Fractionation CentersBlood Typing and Grouping Reagent Market ForecastBy Major TestU.S.A., Military Blood Banks Blood TypingAnd Grouping Reagent Market Forecast by Major TestU.S.A., All Market Segments InfectiousDisease Screening Reagent Market by Market ForecastSegmentU.S.A., All Market Segments InfectiousDisease Screening Reagent Market by Market ForecastSegmentU.S.A., Community and Regional CentersInfectious Disease Screening Reagent Market ForecastBy TestU.S.A., Plasma Fractionation CentersInfectious Disease Screening Reagent Market ForecastBy TestU.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market ForecastBy TestU.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By Test U.S.A., Major Suppliers of Blood TypingAnd Grouping Reagents Estimated Sales And Market SharesU.S.A., HIV/HTLV Blood Screening Market,Reagent Sales by Major SupplierU.S.A., Hepatitis Blood Screening Market,Reagents Sales by Major SupplierU.S.A., Hepatitis C Blood Screening Market,Reagent Sales By Major SupplierU.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major SupplierU.S.A., West Nile Virus NAT Market,Reagent Sales by Major SupplierU.S.A., CMV Blood Screening Market,Reagent Sales by Major SupplierU.S.A., Syphilis Blood Screening Market,Reagent Sales by Major Supplier

To order this report: 2014 Opportunities in the US Blood Banking Market http://www.reportlinker.com/p01622683/2014-Opportunities-in-the-US-Blood-Banking-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________Contact Clare: clare@reportlinker.com US: (339)-368-6001Intl: +1 339-368-6001

SOURCE Reportlinker

RELATED LINKShttp://www.reportlinker.com